Global Gamma Probe Device Market Size By Type (Standalone, Mobile), By Application (Parathyroid Surgery, Sentinel Lymph Node Mapping), By Region, And Segment Forecasts, 2023 to 2032

The Global Gamma Probe Device Market was valued at USD 98.4 million in 2023 and is projected to surpass USD 174.6 million by 2031, growing at a CAGR of 7.3% during the forecast period of 2023–2031. The increasing use of gamma probes in sentinel lymph node biopsies (SLNB), especially for cancer surgeries, is a major growth driver. With the global rise in cancer cases and the growing focus on precision in surgical procedures, gamma probes are becoming essential tools for intraoperative localization. The market is also benefiting from the miniaturization of devices, advances in imaging technology, and increasing adoption across emerging markets.

Drivers:

Rising Incidence of Cancer:

An increase in breast cancer, melanoma, and other cancers has led to a surge in procedures like sentinel lymph node biopsies where gamma probes play a vital role, thus boosting demand globally.

Technological Advancements in Imaging:

Modern gamma probe devices now offer enhanced detection accuracy, ergonomic design, and real-time feedback, facilitating improved surgical precision and patient outcomes.

Growing Adoption of Minimally Invasive Surgeries:

As hospitals increasingly favor less invasive procedures, gamma probes are being used more frequently due to their ability to guide surgeons with real-time radio-guidance.

Restraints:

High Cost of Advanced Devices:

The initial costs of acquiring gamma probe systems, along with maintenance and regulatory compliance, may restrict adoption, especially in smaller healthcare centers or developing nations.

Lack of Awareness and Training:

In several regions, the benefits of gamma probe-guided surgery are still under-recognized due to a lack of training programs and professional expertise, hindering broader adoption.

Opportunity:

Expanding Applications Beyond Oncology:

Although cancer detection remains the key application, gamma probes are gradually being utilized in other fields like endocrinology (parathyroid surgeries), offering new avenues for market growth.

Emerging Markets in Asia-Pacific and Latin America:

The rapid improvement in healthcare infrastructure and growing cancer screening initiatives in these regions present lucrative opportunities for gamma probe device manufacturers.

Market by System Type Insights:

In 2023, the Handheld Gamma Probe segment accounted for the largest market share due to its portability, ease of use, and accuracy during SLNB procedures. These devices are increasingly preferred in operating rooms for their user-friendly nature and ability to integrate seamlessly with surgical workflows.

However, Wireless Gamma Probes are projected to witness the fastest growth due to advancements in battery technology and demand for greater surgeon mobility during procedures.

Market by End-use Insights:

Hospitals emerged as the largest end-use segment in 2023, owing to the high volume of cancer-related surgeries performed in hospital settings. The availability of skilled surgeons, advanced surgical infrastructure, and insurance coverage further support hospital dominance.

The Ambulatory Surgical Centers (ASCs) segment is poised for notable growth, driven by the trend towards outpatient minimally invasive procedures and rising cost-efficiency demands.

Market by Regional Insights:

North America held the dominant share in 2023 due to well-established cancer screening programs, advanced surgical practices, and the presence of major market players. Meanwhile, Asia-Pacific is expected to register the fastest CAGR through 2031. Growing awareness, government initiatives for cancer care, and improving healthcare infrastructure in countries like China and India are driving regional growth.

Competitive Scenario:

Prominent players in the global gamma probe device market include:

Devicor Medical Products, Inc. (part of Leica Biosystems)

IntraMedical Imaging LLC

Hologic, Inc.

Eurorad S.A.

SOFIE Biosciences

Care Wise Medical Products Corp

Eckert & Ziegler Group

Neoprobe Corporation

These companies are actively engaged in product innovation, strategic collaborations, and expanding their geographical footprint to strengthen their market presence. For instance:

In 2023, Hologic, Inc. launched a new high-sensitivity gamma probe system designed specifically for breast-conserving surgeries.

In 2024, Neoprobe Corporation introduced a portable probe with integrated AI for improved intraoperative decision-making support.

Scope of Work – Global Gamma Probe Device Market

Report Metric Details

Market Size (2023) USD 98.4 million

Projected Market Size (2031) USD 174.6 million

CAGR (2023–2031) 7.3%

Market Segments System Type (Handheld, Wireless), End-use (Hospitals, ASCs)

Growth Drivers Rising cancer incidence, advanced surgical imaging, minimally invasive trends

Opportunities Expanding applications beyond oncology, growth in emerging markets

Key Market Developments:

May 2023: Devicor Medical expanded its global footprint by establishing a dedicated gamma probe R&D facility in Germany focused on oncology applications.

January 2024: SOFIE Biosciences announced a collaboration with a leading cancer center to evaluate next-generation gamma probes in clinical trials.

March 2025: Eurorad S.A. received CE Mark for a new gamma probe system integrated with AI-assisted targeting features for improved diagnostic accuracy